ValueQ4, 24TTMCash from investing activities——Cash from financing activities——Free cash flow——
Cellectis S.A. - American Depositary Shares
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.